The Kidney Cancer Research Alliance (KCCure) announced today that Brigham and Women’s researcher, Dr. Lisa Henske has been selected to receive the KCCure Chromophobe Research Grant Award of $50,000 for her proposal: Targeting KIT in Chromophobe Kidney Cancer.
This is the third annual KCCure research grant awarded for Chromophobe Renal Cell Carcinoma (ChRCC), and the second grant to be awarded to Dr. Henske. ChRCC is a rare subtype of kidney cancer accounting for roughly 5 percent of RCC tumors. When discovered early, this histological type is less likely to spread to other parts of the body. However, once the disease becomes metastatic, survival rates are poor. Despite significant advances for patients with the most common type of kidney cancer, research has lagged for patients with advanced chromophobe RCC…
Excerpt from KCCure